Literature DB >> 26283332

Role of Inflammatory Monocytes in Vaccine-Induced Reduction of Helicobacter felis Infection.

Mati Moyat1, Matthias Mack2, Hanifa Bouzourene3, Dominique Velin4.   

Abstract

Despite the proven ability of immunization to reduce Helicobacter infection in mouse models, the precise mechanism of protection has remained elusive. In this study, we evaluated the role of inflammatory monocytes in the vaccine-induced reduction of Helicobacter felis infection. We first showed by using flow cytometric analysis that Ly6C(low) major histocompatibility complex class II-positive chemokine receptor type 2 (CCR2)-positive CD64(+) inflammatory monocytes accumulate in the stomach mucosa during the vaccine-induced reduction of H. felis infection. To determine whether inflammatory monocytes played a role in the protection, these cells were depleted with anti-CCR2 depleting antibodies. Indeed, depletion of inflammatory monocytes was associated with an impaired vaccine-induced reduction of H. felis infection on day 5 postinfection. To determine whether inflammatory monocytes had a direct or indirect role, we studied their antimicrobial activities. We observed that inflammatory monocytes produced tumor necrosis factor alpha and inducible nitric oxide synthase (iNOS), two major antimicrobial factors. Lastly, by using a Helicobacter in vitro killing assay, we showed that mouse inflammatory monocytes and activated human monocytes killed H. pylori in an iNOS-dependent manner. Collectively, these data show that inflammatory monocytes play a direct role in the immunization-induced reduction of H. felis infection from the gastric mucosa.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26283332      PMCID: PMC4598413          DOI: 10.1128/IAI.01026-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  54 in total

1.  A novel population of Gr-1+-activated macrophages induced during acute toxoplasmosis.

Authors:  Dana G Mordue; L David Sibley
Journal:  J Leukoc Biol       Date:  2003-09-12       Impact factor: 4.962

2.  Safety of oral immunisation with recombinant urease in patients with Helicobacter pylori infection.

Authors:  C Kreiss; T Buclin; M Cosma; I Corthésy-Theulaz; P Michetti
Journal:  Lancet       Date:  1996-06-08       Impact factor: 79.321

3.  Depletion of neutrophils in IL-10(-/-) mice delays clearance of gastric Helicobacter infection and decreases the Th1 immune response to Helicobacter.

Authors:  Hanan F Ismail; Pamela Fick; Juan Zhang; Richard G Lynch; Daniel J Berg
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

4.  Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial.

Authors:  Kazutoshi Fukase; Mototsugu Kato; Shogo Kikuchi; Kazuhiko Inoue; Naomi Uemura; Shiro Okamoto; Shuichi Terao; Kenji Amagai; Shunji Hayashi; Masahiro Asaka
Journal:  Lancet       Date:  2008-08-02       Impact factor: 79.321

5.  Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii.

Authors:  Ildiko R Dunay; Renato A Damatta; Blima Fux; Rachel Presti; Suellen Greco; Marco Colonna; L David Sibley
Journal:  Immunity       Date:  2008-08-15       Impact factor: 31.745

6.  TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection.

Authors:  Natalya V Serbina; Thais P Salazar-Mather; Christine A Biron; William A Kuziel; Eric G Pamer
Journal:  Immunity       Date:  2003-07       Impact factor: 31.745

7.  Blood monocytes consist of two principal subsets with distinct migratory properties.

Authors:  Frederic Geissmann; Steffen Jung; Dan R Littman
Journal:  Immunity       Date:  2003-07       Impact factor: 31.745

8.  Vaccination of mice against H pylori induces a strong Th-17 response and immunity that is neutrophil dependent.

Authors:  Elizabeth S DeLyria; Raymond W Redline; Thomas G Blanchard
Journal:  Gastroenterology       Date:  2008-09-20       Impact factor: 22.682

9.  Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers.

Authors:  S Banerjee; A Medina-Fatimi; R Nichols; D Tendler; M Michetti; J Simon; C P Kelly; T P Monath; P Michetti
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

10.  Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses.

Authors:  T H Ermak; P J Giannasca; R Nichols; G A Myers; J Nedrud; R Weltzin; C K Lee; H Kleanthous; T P Monath
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

View more
  10 in total

Review 1.  The Immune Battle against Helicobacter pylori Infection: NO Offense.

Authors:  Alain P Gobert; Keith T Wilson
Journal:  Trends Microbiol       Date:  2016-02-22       Impact factor: 17.079

2.  IL-22-induced antimicrobial peptides are key determinants of mucosal vaccine-induced protection against H. pylori in mice.

Authors:  M Moyat; H Bouzourene; W Ouyang; J Iovanna; J-C Renauld; D Velin
Journal:  Mucosal Immunol       Date:  2016-05-04       Impact factor: 7.313

3.  Divergent roles for Ly6C+CCR2+CX3CR1+ inflammatory monocytes during primary or secondary infection of the skin with the intra-phagosomal pathogen Leishmania major.

Authors:  Audrey Romano; Matheus B H Carneiro; Nicole A Doria; Eric H Roma; Flavia L Ribeiro-Gomes; Ehud Inbar; Sang Hun Lee; Jonatan Mendez; Andrea Paun; David L Sacks; Nathan C Peters
Journal:  PLoS Pathog       Date:  2017-06-30       Impact factor: 6.823

4.  Skin-resident CD4+ T cells protect against Leishmania major by recruiting and activating inflammatory monocytes.

Authors:  Nelson D Glennie; Susan W Volk; Phillip Scott
Journal:  PLoS Pathog       Date:  2017-04-18       Impact factor: 6.823

5.  CCR2+ Monocyte-Derived Infiltrating Macrophages Are Required for Adverse Cardiac Remodeling During Pressure Overload.

Authors:  Bindiya Patel; Shyam S Bansal; Mohamed Ameen Ismahil; Tariq Hamid; Gregg Rokosh; Matthias Mack; Sumanth D Prabhu
Journal:  JACC Basic Transl Sci       Date:  2018-03-14

6.  GM-CSF is key in the efficacy of vaccine-induced reduction of Helicobacter pylori infection.

Authors:  Laurie Vaillant; Paul Oster; Brynn McMillan; Eulalia Orozco Fernandez; Dominique Velin
Journal:  Helicobacter       Date:  2022-01-29       Impact factor: 5.182

7.  Immune defects associated with lower SARS-CoV-2 BNT162b2 mRNA vaccine response in aged people.

Authors:  Joana Vitallé; Alberto Pérez-Gómez; Francisco José Ostos; Carmen Gasca-Capote; María Reyes Jiménez-León; Sara Bachiller; Inmaculada Rivas-Jeremías; Maria Del Mar Silva-Sánchez; Anabel M Ruiz-Mateos; María Ángeles Martín-Sánchez; Luis Fernando López-Cortes; Mohammed Rafii-El-Idrissi Benhnia; Ezequiel Ruiz-Mateos
Journal:  JCI Insight       Date:  2022-09-08

Review 8.  Use of VacA as a Vaccine Antigen.

Authors:  Mati Moyat; Dominique Velin
Journal:  Toxins (Basel)       Date:  2016-06-08       Impact factor: 4.546

9.  The frequency of circulating integrin α4β7+ cells correlates with protection against Helicobacter pylori infection in immunized mice.

Authors:  Sarmin Akter; Frida Jeverstam; Anna Lundgren; Maria K Magnusson; Anna Walduck; Firdausi Qadri; Taufiqur Rahman Bhuiyan; Sukanya Raghavan
Journal:  Helicobacter       Date:  2019-09-09       Impact factor: 5.753

10.  Silk fibroin hydrogel as mucosal vaccine carrier: induction of gastric CD4+TRM cells mediated by inflammatory response induces optimal immune protection against Helicobacter felis.

Authors:  Chupeng Hu; Wei Liu; Ningyin Xu; An Huang; Zhenxing Zhang; Menghui Fan; Guojing Ruan; Yue Wang; Tao Xi; Yingying Xing
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.